32 related articles for article (PubMed ID: 22776956)
1. Development and validation of a sensitive LC-MS/MS method for the determination of fenoterol in human plasma and urine samples.
Sanghvi M; Ramamoorthy A; Strait J; Wainer IW; Moaddel R
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 933():37-43. PubMed ID: 23872161
[TBL] [Abstract][Full Text] [Related]
2. Functions of beta2-adrenergic receptor in human periodontal ligament cells.
Hamano S; Tomokiyo A; Hasegawa D; Yuda A; Sugii H; Yoshida S; Mitarai H; Wada N; Maeda H
J Cell Biochem; 2020 Dec; 121(12):4798-4808. PubMed ID: 32115771
[TBL] [Abstract][Full Text] [Related]
3. β‑adrenergic receptor activation promotes the proliferation of HepG2 cells via the ERK1/2/CREB pathways.
Lin X; He J; Liu F; Li L; Sun L; Niu L; Xi H; Zhan Y; Liu X; Hu P
Oncol Lett; 2023 Dec; 26(6):519. PubMed ID: 37927415
[TBL] [Abstract][Full Text] [Related]
4. Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the β₂-adrenergic receptor.
Plazinska A; Pajak K; Rutkowska E; Jimenez L; Kozocas J; Koolpe G; Tanga M; Toll L; Wainer IW; Jozwiak K
Bioorg Med Chem; 2014 Jan; 22(1):234-46. PubMed ID: 24326276
[TBL] [Abstract][Full Text] [Related]
5. Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death.
Shoeib AM; Benson LN; Mu S; MacMillan-Crow LA; Prather PL
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328467
[TBL] [Abstract][Full Text] [Related]
6. Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β
Wnorowski A; Dudzik D; Bernier M; Wójcik J; Keijzers G; Diaz-Ruiz A; Mazur K; Zhang Y; Han H; Scheibye-Knudsen M; Jozwiak K; Barbas C; Wainer IW
Sci Rep; 2022 Mar; 12(1):3618. PubMed ID: 35256673
[TBL] [Abstract][Full Text] [Related]
7. β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma.
Ghali GZ; Ghali MGZ
Mol Biol Rep; 2020 Jun; 47(6):4631-4650. PubMed ID: 32303958
[TBL] [Abstract][Full Text] [Related]
8. Activation of β-adrenergic receptor promotes cellular proliferation in human glioblastoma.
He JJ; Zhang WH; Liu SL; Chen YF; Liao CX; Shen QQ; Hu P
Oncol Lett; 2017 Sep; 14(3):3846-3852. PubMed ID: 28927156
[TBL] [Abstract][Full Text] [Related]
9. GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts.
Bernier M; Catazaro J; Singh NS; Wnorowski A; Boguszewska-Czubara A; Jozwiak K; Powers R; Wainer IW
Int J Cancer; 2017 Nov; 141(10):2131-2142. PubMed ID: 28741686
[TBL] [Abstract][Full Text] [Related]
10. Selective GPR55 antagonism reduces chemoresistance in cancer cells.
Singh NS; Bernier M; Wainer IW
Pharmacol Res; 2016 Sep; 111():757-766. PubMed ID: 27423937
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of (R,R')-4-methoxy-1-naphthylfenoterol in a rat C6 glioma xenograft model in the mouse.
Bernier M; Paul RK; Dossou KS; Wnorowski A; Ramamoorthy A; Paris A; Moaddel R; Cloix JF; Wainer IW
Pharmacol Res Perspect; 2013 Dec; 1(2):e00010. PubMed ID: 25505565
[TBL] [Abstract][Full Text] [Related]
12. (R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motility.
Paul RK; Wnorowski A; Gonzalez-Mariscal I; Nayak SK; Pajak K; Moaddel R; Indig FE; Bernier M; Wainer IW
Biochem Pharmacol; 2014 Feb; 87(4):547-61. PubMed ID: 24355564
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cells.
Paul RK; Ramamoorthy A; Scheers J; Wersto RP; Toll L; Jimenez L; Bernier M; Wainer IW
J Pharmacol Exp Ther; 2012 Oct; 343(1):157-66. PubMed ID: 22776956
[TBL] [Abstract][Full Text] [Related]
14. Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.
Wnorowski A; Sadowska M; Paul RK; Singh NS; Boguszewska-Czubara A; Jimenez L; Abdelmohsen K; Toll L; Jozwiak K; Bernier M; Wainer IW
Cell Signal; 2015 May; 27(5):997-1007. PubMed ID: 25703025
[TBL] [Abstract][Full Text] [Related]
15. Concurrent activation of β
Wnorowski A; Such J; Paul RK; Wersto RP; Indig FE; Jozwiak K; Bernier M; Wainer IW
Cell Signal; 2017 Aug; 36():176-188. PubMed ID: 28495590
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
